Image-based methods such as computed tomography for assessing body composition
enables quantification of muscle mass and muscle density and reveals that low muscle …

Upwards of 50% of newly diagnosed advanced lung cancer patients have severe muscle
wasting (sarcopenia). Supplementation with eicosapentaenoic acid (EPA) and …

Loss of skeletal muscle mass is a characteristic feature of various pathologies including
cancer, diabetes, and obesity, as well as being a general feature of ageing. However, the …

Skeletal muscle volume is associated with prognosis of cancer patients. Maintenance of
skeletal muscle is an essential concern in cancer treatment. In nutritional intervention, it is …

Sarcopenic obesity is characterised by high fat mass, low muscle mass and an elevated
inflammatory environmental milieu. We therefore investigated the effects of elevated …

Impaired regeneration and consequent muscle wasting is a major feature of muscle
degenerative diseases. Nutritional interventions such as adjuvant strategy for preventing …

Background Eicosapentaenoic acid (EPA) is a ώ-3 polyunsaturated fatty acid with anti-
inflammatory and anti-cachetic properties that may have potential benefits with regards to …

Skeletal muscle is essential for human locomotion as well as maintaining metabolic
homeostasis. Age-related reduction in skeletal muscle mass, strength, and function (ie …

Objectives The objective of this review article is to present the most recent intervention
studies with EPA on nutritional outcomes in cancer patients, eg nutritional status, weight & …

Ingestion of omega-3 fatty acids is known to exert favorable health effects on a number of
biological processes such as improved immune profile, enhanced cognition, and optimized …